Doximity’s stock skyrockets 50% on medical AI excitement. Can the rally last?
MarketWatch· Hannah Pedone· Aug 7, 2026 · 3:36 PM
While one analyst thinks Doximity has a compelling AI opportunity, another worries that the company could cannibalize its core business of medical networking.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 5 hours ago
Financial stocks are falling below a key chart level to warn the worst is yet to come
Financial stocks have struggled over the past several weeks, and it’s becoming clear the decline may not be over.
MarketWatch
marketsabout 6 hours ago
This silent alarm in the bond market tells you which stocks to buy and which to avoid
Widening credit spreads send an important signal that investors should heed about which stocks to buy and which to avoid
MarketWatch
marketsabout 7 hours ago
Trump’s SEC wants to allow fund managers to charge extra fees for better performance. Here’s why it’s a terrible idea.
Think twice before embracing any new fund with high performance-related fees in your 401(k).
MarketWatch